Denison Increases Bought Deal Offering to US$17.4 Million
1
Denison Mines Corp.
1100 – 40 University Ave
Toronto, ON M5J 1T1
www.denisonmines.com
PRESS RELEASE
DENISON INCREASES BOUGHT DEAL OFFERING TO US$17.4 MILLION
Toronto, ON – October 8, 2020 Denison Mines Corp. (“Denison” or the “Company”) (DML: TSX, DNN:
NYSE American) is pleased to announce that it has agreed with Cantor Fitzgerald Canada Corporation
("CFCC") and Haywood Securities Inc. ("Haywood"), as co-lead underwriters and joint book-runners (the
"Co-Lead Underwriters") on behalf of themselves and a syndicate of underwriters, including Canaccord
Genuity Corp., Scotia Capital Inc. and TD Securities Inc. (collectively with CFCC and Haywood, the
"Underwriters"), in connection with the previously announced bought deal offering of common shares of the
Company (the “Offered Shares”) at a price of US$0.37 per Offered Share (the “Issue Price”), to increase
the size of the offering to 47,000,000 Offered Shares for aggregate gross proceeds of approximately
US$17.4 million (the “Offering”).
In addition, Denison has agreed to grant to the Underwriters an over-allotment option (the "Over-Allotment
Option") exercisable, in whole or in part, at the sole discretion of the Underwriters to purchase up to an
additional 7,050,000 Offered Shares at the Issue Price for a period of up to 30 days after the closing of the
Offering, for potential additional gross proceeds to Denison of up to approximately US$2.6 million.
Proceeds of the Offering are anticipated to be used to fund evaluation and environmental assessment
activities on Denison's Wheeler River project, as well as for general working capital purposes.
Denison will pay to the Underwriters a cash commission equal to 6.0% of the gross proceeds of the
Offering, including any proceeds received from the exercise of the Over-Allotment Option.
The Offering is expected to close on or about October 14, 2020 and is subject to certain conditions
including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto
Stock Exchange and the NYSE American.
The Offering will be made by way of a prospectus supplement (the “Prospectus Supplement”) to the
Company's existing Canadian short form base shelf prospectus (the "Base Shelf Prospectus") and U.S.
registration statement on Form F-10, as amended (File No. 333-238108) (the "Registration Statement"),
each dated June 2, 2020. The Registration Statement was declared effective by the United States
Securities and Exchange Commission (the "SEC") on June 3, 2020. The Prospectus Supplement has been
filed with the securities commissions in each of the provinces and territories of Canada, except Quebec,
and with the SEC. The Canadian Prospectus Supplement (together with the related Canadian Base Shelf
Prospectus) is available on the SEDAR website maintained by the Canadian Securities Administrators at
www.sedar.com. The U.S. Prospectus Supplement (together with the related U.S. Base Shelf Prospectus)
is available on the SEC's website at www.sec.gov. Alternatively, the Prospectus Supplement and related
Base Shelf Prospectus may be obtained upon request by contacting the Company or Cantor Fitzgerald
Canada Corporation in Canada, attention: Equity Capital Markets, 181 University Avenue, Suite
1500, Toronto, ON, M5H 3M7, email: [email protected]; Cantor Fitzgerald & Co., Attention: Equity
Capital Markets, 499 Park Avenue, 6th Floor, New York, New York, 10022 or by email at
[email protected] or Haywood Securities Inc., attention: Equity Capital Markets, 200 Burrard Street,
Suite 700, Vancouver, BC, V6C 3L6, email: [email protected].
This press release does not constitute an offer to sell or the solicitation of an offer to buy
securities, nor will there be any sale of the securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or qualification under the securities
laws of any such jurisdiction. The securities being offered have not been approved or disapproved
by any regulatory authority, nor has any such authority passed upon by the accuracy or adequacy
of the Prospectus Supplement, the Base Shelf Prospectus or the Registration Statement.
About Denison
Denison Mines Corp. was formed under the laws of Ontario and is a reporting issuer in all Canadian provinces and
territories. Denison’s common shares are listed on the Toronto Stock Exchange (the ‘TSX’) under the symbol ‘DML’
and on the NYSE American exchange under the symbol ‘DNN’.
Denison is a uranium exploration and development company with interests focused in the Athabasca Basin region of
northern Saskatchewan, Canada. The Company’s flagship project is the 90% owned Wheeler River Uranium Project.
Denison's interests in Saskatchewan also include a 22.5% ownership interest in the McClean Lake Joint Venture
(‘MLJV’), which includes several uranium deposits and the McClean Lake uranium mill, which is currently processing
ore from the Cigar Lake mine under a toll milling agreement, plus a 25.17% interest in the Midwest deposits and a
66.71% interest in the J Zone and Huskie deposits on the Waterbury Lake property. The Midwest, J Zone and Huskie
deposits are located within 20 kilometers of the McClean Lake mill. In addition, Denison has an extensive portfolio of
exploration projects in the Athabasca Basin region.
Denison is engaged in mine decommissioning and environmental services through its Closed Mines group (formerly
Denison Environmental Services), which manages Denison’s Elliot Lake reclamation projects and provides post-closure
mine and maintenance services to a variety of industry and government clients.
Denison is also the manager of Uranium Participation Corporation (‘UPC’), a publicly traded company listed on the TSX
under the symbol ‘U’, which invests in uranium oxide in concentrates (‘U3O8’) and uranium hexafluoride (‘UF6’).
For more information, please contact
David Cates (416) 979-1991 ext. 362
President and Chief Executive Officer
Sophia Shane (604) 689-7842
Investor Relations
Follow Denison on Twitter @DenisonMinesCo
Cautionary Statement Regarding Forward-Looking Statements
Certain information contained in this news release constitutes ‘forward -looking information’, within the meaning of the applicable
United States and Canadian legislation concerning the business, operations and financial performance and condition of Denison.
Generally, these forward -looking statements can be identified by the use of forward -looking terminology such as ‘plans’, ‘expects’,
‘budget’, ‘scheduled’, ‘estimates’, ‘forecasts’, ‘intends’, ‘anticipates’, or ‘believes’, or the negatives and/or variations of such words and
phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will be taken’, ‘occur’, ‘be achieved’ or ‘has the
potential to’.
In part icular, this news release contains forward -looking information pertaining to the following: the likelihood of completion of the
Offering, the use of proceeds from sales from the Offering, the closing of the Offering and the ability to obtain the necessary regulatory
authority and approvals.
Forward looking statements are based on the opinions and estimates of management as of the date such statements are made, and
they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity,
performance or achievements of Denison to be materially different from those expressed or implied by such forward-looking
statements. For example, if market conditions remain volatile and/or COVID-19 mitigation measures result in more social and
economic disruptions, Denison may not be able to complete the Offering on the terms herein described or at all or pursue its
evaluation and environmental assessment activities, which could have significant impacts on Denison. In addition, the currently
anticipated evaluation and environmental assessment activities may not be maintained after further testing or Denison may decide or
otherwise be required to alter or discontinue testing, evaluation and development work, if it is unable to maintain or otherwise secure
the necessary approvals or resources (such as testing facilities, capital funding, etc.). Denison believes that the expectations reflected
in this forward-looking information are reasonable and no assurance can be given that these expectations will prove to be accurate
and results may differ materially from those anticipated in this forward-looking information. For a discussion in respect of risks and
other factors that could influence forward-looking events, please refer to the factors discussed in Denison’s Annual Information Form
dated March 13, 2020 under the heading “Risk Factors”. These factors are not, and should not be construed as being exhaustive
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking information contained in this
news release is expressly qualified by this cautionary statement. Any forward-looking information and the assumptions made with
respect thereto speaks only as of the date of this news release. Denison does not undertake any obligation to publicly update or revise
any forward-looking information after the date of this news release to conform such information to actual results or to changes in
Denison's expectations except as otherwise required by applicable legislation.